Skip to Content

Targeted Therapy for Neurofibromatosis Type-2 Mutated Vestibular Schwannomas

Neurofibromatosis-type 2 Mutated Vestibular Schwannomas is a rare genetic disorder that causes noncancerous tumors to grow on the auditory nerves, leading to hearing loss, tinnitus, and balance issues. In this MEDtalk, Shivani Chiranth from the Department for Cancer Treatment at DCCC Brain Tumor Center, Rigshospitalet in Denmark, presents the results of a systematic review that investigated the effectiveness and potential side effects of bevacizumab in treating patients with this condition.

Shivani Bangalore Chiranth

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top